VAKSX Mutual Fund

VAKSX Mutual Fund

NAV$9.93
See how much of VAKSX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Jun 30, 2026

Net Assets
$318,401.97
Expense Ratio
1.20%
Dividend Yield (Current)
-
Holdings
28
Inception Date
Dec 8, 2020
Fund Family
Virtus Investment Partners
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO

Performance

YTD-0.69%
1 Year-9.61%
3 Year+2.03%
5 Year-1.93%

Asset Allocation

Stocks: 100.00%
See how much of VAKSX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
WSTWest Pharmaceutical Services6.36%
HNGEHinge Health Inc6.03%
AAONAaon, Inc.5.43%
HEI.AHeico Corp. Class A5.41%
TDYTeledyne Technologies Inc4.83%
Top 10 Concentration: 49.34%Report Date: Jun 30, 2026
Download all 28 holdings for VAKSX
CSV export with sector, industry & share changes
Get CSV

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

VAKSX Mutual Fund Overview

VAKSX Mutual Fund (Virtus KAR Small-Mid Cap Growth Fund Class A) is managed by Virtus Investment Partners with $318,401.97 in net assets. VAKSX expense ratio is 1.20%, holding 28 positions across sectors including Industrials, Information Technology, Health Care. Inception date: 2020-12-08.

VAKSX performance shows a YTD return of -0.69%. The 1-year return is -9.61% and the 5-year return is -1.93%.

VAKSX top holdings include West Pharmaceutical Services (6.4%), Hinge Health Inc (6.0%), Aaon, Inc. (5.4%), Heico Corp. Class A (5.4%), Teledyne Technologies Inc (4.8%). Go to all VAKSX holdings, VAKSX sectors, or VAKSX dividends.

VAKSX can be compared against other funds. Use VAKSX overlap to find shared positions, or VAKSX vs another fund for a side-by-side view. VAKSX alternatives are available via the screener, along with tax-loss harvesting opportunities.